Search Results
Results 1 - 50 of 2722
1 2 3 4 5 6 7 8 9 10 >
Ishihara Takayuki - - 2013
A 72-year-old man received an implantation of implantable cardioverter defibrillator with intracardiac electrogram (ICEG) monitoring because ventricular fibrillation occurred in a case of old myocardial infarction with reduced left ventricular function. A year later, he came to our hospital for a regular checkup. Unexpectedly, ST depression was recorded by ICEG ...
Omidvar Bita - - 2013
We discuss a young man with episodes of chest pain and dyspnea accompanied with transient T-wave inversion in precordial and inferior leads that repeated several times. Cardiovascular evaluation did not disclose any structural abnormality. Memory T wave following episodes of idiopathic left septal ventricular tachycardia was the reason of these ...
Sharma Akshay - - 2012
Abstract  Primary cardiac lymphoma (PCL) is an extremely rare diagnosis. We present a case of a 38-year-old immunocompetent female who presented with dyspnea on exertion and chest pain and the echocardiography revealed a mass in the left atrium (LA) causing moderate mitral regurgitation and mimicking a left atrial myxoma. The ...
Lestuzzi Chiara - - 2012
A 23-year-old male presented with severe rest dyspnoea, engorged jugular veins, ankle oedema and heart rate 140 bpm. Computed tomography (CT) scan showed a large mediastinal mass with pericardial and atrial infiltration, pulmonary artery and superior vena cava compression. HIV infection was detected. Echocardiography showed 5 × 4 cm masses both in the ...
Soens Lucie - - 2012
Secondary cardiac lymphoma is commonly recognised as one of the most frequent metastatic malignancies involving the heart, after lung and breast carcinomas. Most primary and secondary cardiac lymphoma are non-Hodgkin lymphomas.The pericardium is the most frequently involved cardiac structure. However, the myocardium and the endocardium can also be affected. The ...
Chen Ke-Wei - - 2012
Primary cardiac lymphoma (PCL) is very rare, and is extremely challenging to diagnose due to nonspecific symptoms. When discovered, the right atrium and ventricle are most commonly affected, while diffuse cardiac involvement is uncommon. PCL is fatal unless promptly diagnosed and treated. Herein, we present the case of a 36-year-old ...
Chemello Diego - - 2011
Systemic non-Hodgkin's lymphoma can affect the myocardium, particularly in immunocompromised patients. When present, symptoms and signs are usually nonspecific, making the diagnosis of cardiac involvement very difficult before an autopsy. Ventricular arrhythmias are also unusual in this setting. We describe a case of secondary myocardial non-Hodgkin's lymphoma presenting with sustained ...
Cella Laura - - 2011
PURPOSE: To identify dose-heart-volume constraints that correlate with the risk of developing asymptomatic valvular defects (VD) in Hodgkin's lymphoma (HL) patients treated with three-dimensional radiotherapy (RT). PATIENTS AND METHODS: Fifty-six patients undergoing cytotoxic chemotherapy (CHT) and involved-field radiation treatment for HL were retrospectively analyzed. Electro-echocardiography was performed before CHT, after ...
Buczinski Sébastien - - 2011
Maintaining a good quality of life for cows with cardiac manifestation of lymphoma may be valuable, especially in high-producing cows. This report describes the medical management of cardiac lymphoma in a cow by means of repeated pericardiocentesis. The cow survived for 34 days and was productive.
Jabre Patricia - - 2011
Atrial fibrillation (AF) often coexists with myocardial infarction (MI), yet its prognostic influence is disputed. Prior reports studied the relationship of AF during early hospitalization for acute MI to the risk of death and could not address the timing of AF in relation to the MI (ie, before, during, after). ...
Macheret Fima F Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Department of Medicine and Physiology, Mayo Clinic, Rochester, Minnesota, USA. - - 2011
The purpose of this study was to investigate circulating pro-B-type natriuretic peptide (proBNP(1-108)) in the general community and evaluate its ability to detect left ventricular (LV) dysfunction. The current concept for cardiac endocrine function is that, in response to cardiac stress, the heart secretes B-type natriuretic peptide (BNP(1-32)) and amino-terminal ...
Sgueglia Gregory A - - 2011
Drug-eluting stents (DES) have revolutionized the treatment of coronary bifurcation lesions. Among different DES types, sirolimus-eluting stents (SES) showed better outcomes than paclitaxel-eluting stents. Because novel sirolimus analogues have been implemented in DES, a prospective observational comparison was undertaken to compare major mammalian target of rapamycin inhibitor-eluting stents in the ...
Chaturvedi Abhishek - - 2011
Cardiac angiosarcoma is the most common of the cardiac sarcomas. It can infiltrate into adjacent structures in addition to seeding distant metastases. Coronary artery encasement is a rare but potentially life-threatening complication of cardiac angiosarcoma. We report a case of cardiac angiosarcoma encasing the right coronary artery with subsequent pseudoaneurysm ...
McManus David D - - 2012
Obesity is associated with pathological cardiac remodeling and risk of heart failure (HF). Adipocytokines (ADKs) may mediate the increased risk of cardiovascular disease associated with excess adiposity. Yet data relating ADKs to cardiac remodeling phenotypes are sparse. We related two circulating ADKs, resistin and adiponectin, to three important echocardiographic markers ...
Alsuhaibani Adel H - - 2011
Infarction of the orbital bone in patients with sickle cell disease is very rare. The authors report a young boy who presented twice with marked acute proptosis and eyelid swelling of the right eye resulting from infarction in the greater wing of the sphenoid bone accompanied by an orbital subperiosteal ...
Fragaki Konstantina - - 2011
The role of a secondary respiratory chain deficiency as an additional mechanism to intoxication, leading to development of long-term energy-dependent complications, has been recently suggested in patients with propionic acidemia (PA). We show for the first time a coenzyme Q(10) (CoQ(10)) functional defect accompanied by a multiple organ oxidative phosphorylation ...
Ottaviano Filomena G - - 2011
Interspersed between cardiac myocytes, cardiac fibroblasts serve mainly as a structural support during ventricular wall thickening from embryogenesis until adulthood. Cardiac fibroblasts, however, may also serve as a source of mitogens, extracellular matrix proteins, cytokines, and growth factors that could affect the phenotype of the cardiac myocyte. The crosstalk between ...
Zamani Payman - - 2011
Objectives: To compare the long-term risks of coronary bifurcation lesions treated with side-branch stenting using drug-eluting versus bare-metal stents. Background: Side-branch stenting is an off-label practice, but when needed, the incidence of late adverse events may differ between drug-eluting and bare-metal stents. Methods: We systematically searched PubMed, and the National ...
McCulloch Brenda - - 2011
The Impella 2.5 is a percutaneously placed partial circulatory assist device that is increasingly being used in high-risk coronary interventional procedures to provide hemodynamic support. The Impella 2.5 is able to unload the left ventricle rapidly and effectively and increase cardiac output more than an intra-aortic balloon catheter can. Potential ...
Luk Adriana - - 2011
We report a case of a 51-year-old man who was transferred from a community hospital to our institution in cardiogenic shock after thrombolytic therapy for myocardial infarction. At autopsy, a cor triatriatum sinister was found. This may have contributed to his poor outcome post infarction.
Cheriyath Pramil - - 2011
Ventricular premature complexes (VPCs) and atrial premature complexes (APCs) are common findings on routinely obtained electrocardiograms. Despite their common occurrence, the significance of these irregular beats is unclear, especially with regard to risk of sudden cardiac death (SCD). In this study, we examined the prospective relation between baseline VPCs or ...
Kumar Prabhat - - 2011
Left ventricular myxoma are quite rare and have not been reported in children. We report a left ventricular myxoma arising from interventricular septum in a 12-year-old girl who presented with history of single episode of syncope while playing in school. General examination of the child did not reveal any abnormality ...
Sirbu Vasile - - 2011
The use of drug-eluting stents (DES) allowed the reduction in the need for repeat revascularization. At the culprit site in acute myocardial infarction patients treated with first-generation DES, the interaction between the eluted drug and the underlying necrotic core may generate different patterns of pathologic vessel response and delayed healing. ...
Frikha Zied - - 2011
Primary cardiac lymphoma is rare. We report the case of a 64-year-old non-immunodeficient Caucasian man, with cardiac tamponade and paroxysmal third-degree atrioventricular block. Echocardiography revealed the presence of a large pericardial effusion with signs of tamponade and a right ventricular mass was suspected. Scanner investigations clarified the sites, extension and ...
Emmert Maximilian Y - - 2011
After the delivery of her second child, peripartum cardiomyopathy developed in the 33-year-old mother, which was complicated by cardiogenic shock refractory to medical treatment. A left ventricular assist device was implanted, and bromocriptine therapy was given to facilitate myocardial recovery. Serial echocardiographic, hemodynamic, and exercise tests under full and partial ...
Girish M P - - 2011
Complication due to hardware failure may happen even in the most straightforward interventional procedures. We report an unusual complication of nondeflation of coronary stent balloon entrapped within the coronary tree. The nondeflated balloon was retrieved percutaneously by a simple technique.
Prestia Kevin A - - 2011
Increasing connexin43 (Cx43) gap junctional conductance as a means to improve cardiac conduction has been proposed as a novel antiarrhythmic modality. Yet, transmission of molecules via gap junctions may be associated with increased infarct size. To determine whether maintaining open gap junction channels impacts on infarct size and induction of ...
Vanninen Sari U M SU Department of Cardiology, Heart Center, Tampere University Hospital, PL 2000, 33521 Tampere, - - 2011
Incorrect lead placement may result in unnecessary therapeutic interventions. We present a case report of 53-year-old man with new inferior T-wave inversions in the 12-lead electrocardiogram (ECG) noted during routine followup of hypertension without any cardiovascular symptoms.
Garg Scot - - 2011
This report describes the 4-year clinical outcomes of the SPIRIT II study, which randomized 300 patients to treatment with the XIENCE V everolimus-eluting stent (EES), or the TAXUS paclitaxel-eluting stent. At 4-year clinical follow-up, which was available in 256 (85.3%) patients, treatment with EES lead to a trend for lower ...
Desai Ravi V - - 2011
Presence of concentric left ventricular (LV) geometry has important pathophysiologic and prognostic implications. However, little is known about its natural history in older adults. Of the 5,795 community-dwelling adults ≥65 years of age in the Cardiovascular Health Study, 1,871 without baseline heart failure had data on baseline and 7-year echocardiograms. ...
Rodriguez Alfredo E - - 2011
The aim of this study was the comparison of a new double-coated paclitaxel-eluting coronary stent with bare-metal stent (BMS) in patients undergoing percutaneous coronary intervention. Stent coating with biodegradable polymers as a platform for elution of drugs has the potential for complete elution of drugs and for decreasing the risk ...
Ormiston John A - - 2010
Drug-eluting stents reduce restenosis and reintervention rates but are complicated by stent thrombosis, which may be related to polymer coating. The NEVO sirolimus-eluting coronary stent (NEVO SES) is designed to improve long-term percutaneous coronary intervention safety by combining sirolimus release from reservoirs with bioabsorbable polymer to reduce spatial and temporal ...
Chen Tzong-Huei - - 2010
Whereas the development of coronary stents has been a major breakthrough in the treatment of coronary artery disease, stent thrombosis, associated with myocardial infarction and death, has introduced a new challenge in the care of patients with coronary stents undergoing noncardiac surgery. This review presents the authors' recommendations regarding the ...
Ikenaga Hiroki - - 2010
Sirolimus-eluting stents (SES) are now commonly used for percutaneous coronary intervention (PCI) because they dramatically reduce the rates of restenosis and target lesion revascularization, even in small vessels and long lesions as compared with bare-metal stent. The unresolved issue about SES use is the possibility of late stent thrombosis. Late ...
Imola Fabrizio - - 2010
The purpose of this single centre registry is to assess safety and feasibility of the frequency domain optical coherence tomography (FD-OCT) system during coronary interventions. Ninety patients with unstable or stable coronary artery disease were included in this study. OCT imaging was performed in a first group of 40 patients ...
Dudek Dariusz - - 2010
The MGuard stent (bare metal stent wrapped externally with a polymer mesh sleeve) is designed to prevent distal embolisation by reducing thrombus and plaque fragments released during and post percutaneous coronary intervention (PCI). The aim of this study was to confirm the clinical feasibility, safety and performance of the MGuard ...
Capranzano Piera - - 2010
Although drug-eluting stents (DES) have reduced restenosis in a broad range of lesions, there is limited data, from relatively small studies, on the safety and efficacy of DES for isolated ostial left anterior descending (LAD) stenoses. In addition, in the setting of these high-risk lesions, there is the issue of ...
Pepe Martino - - 2011
Percutaneous treatment of unprotected left main coronary artery (ULMCA) stenosis using drug-eluting stents (DES) has been suggested as the best approach for patients who are poor surgical candidates. Some concerns have recently been raised regarding the risk of stent thrombosis following DES implantation. This study was performed in order to ...
Demir Ahmet Duran AD Department of Cardiology, Yuksek Ihtisas Heart-Education and Research Hospital, Ankara, - - 2010
Cardiac resynchronization therapy has been increasingly used for patients with heart failure. However, unstable and dislocated coronary sinus leads reduce the effectiveness of this important intervention. To examine the long-term effects of coronary sinus side branch stenting on sensing and pacing parameters of the left ventricular leads. A total of ...
Ostojic Miodrag C - - 2011
This prospective, open-label multicenter study was conducted to assess the pharmacokinetics of Biolimus A9 after elution from BioMatrix II coronary stents. Recent clinical trials have demonstrated the efficacy and safety of Biolimus A9 eluted from different stent platforms. To date, the pharmacokinetics of Biolimus A9 in patients following the deployment ...
Park Duk-Woo - - 2010
The aim of this study was to evaluate the relative efficacy and safety of zotarolimus-eluting stents (ZES) in comparison with the established and widely used sirolimus- (SES) and paclitaxel-eluting stents (PES) in routine clinical practice. Whether ZES might provide similar clinical and angiographic outcomes in a broad spectrum of patients ...
Kim Kyung-Hee - - 2012
It is unknown whether drug-eluting stents (DES), in comparison with bare-metal stents (BMS), improve clinical outcomes of ST-elevation myocardial infarction (STEMI) patients with renal insufficiency. We aimed to compare the clinical outcomes of BMS versus DES, as well as sirolimus-eluting stents (SES) versus paclitaxel-eluting stents (PES), in STEMI patients with ...
Leon Martin B - - 2010
The increased frequency of very late (>1 year) stent thrombosis (VLST) has raised concerns with regard to the safety of sirolimus-eluting stents and paclitaxel-eluting stents (PES). Experimental and preliminary clinical findings with the zotarolimus-eluting stent (ZES) have suggested a favorable safety profile. The ENDEAVOR IV (Randomized Comparison of Zotarolimus- and ...
Stone Gregg W - - 2010
We sought to identify patients with ST-segment elevation myocardial infarction most likely to benefit from drug-eluting stents (DES), and to evaluate the impact of routine angiographic follow-up on the apparent differences between stent types. DES might have greatest utility in patients who would benefit most from their antirestenotic properties. We ...
Gavrielatos Gerasimos - - 2010
The Intek-Apollo stent (Switzerland) employs a polysulfone polymer coating which has demonstrated low interaction with blood and high thrombo-resistance. The aim of this study was to assess the clinical and angiographic outcomes after Intek-Apollo stent utilisation in a real-world setting. A total of 130 patients (77.7% males) were enrolled with ...
Brilakis Emmanouil S - - 2010
To review the contemporary management of patients with coronary stents in the ICU. Coronary stent patients admitted in the ICU may be at increased risk for stent thrombosis, a catastrophic complication with high morbidity and mortality. Dual antiplatelet therapy with aspirin and a P2Y12 receptor antagonist significantly reduces the risk ...
Talarico Giovanni Paolo - - 2010
The use of thrombus aspiration during percutaneous coronary intervention (PCI) is recommended in patients with ST-elevation myocardial infarction (STEMI) undergoing mechanical revascularization. When thrombus aspiration is adopted, the standard technique includes, after mechanical thrombus extraction, angioplasty and/or stent implantation to eliminate residual stenosis. To date, no data are available concerning ...
Claessen Bimmer E - - 2010
The introduction of drug-eluting stents has led to a marked reduction of restenosis, which is a major limitation of percutaneous coronary intervention for coronary artery disease. The next-generation Xience V® (Abbott Vascular, CA, USA) everolimus-eluting stent was designed to address the limitations of first-generation drug-eluting stents. The cobalt-chromium stent platform ...
Kim Hyun-Tae - - 2010
The absolute benefit of drug-eluting stents (DES) in low-risk patients and lesions is not well established. The long term clinical outcomes after percutaneous coronary intervention in a single coronary artery disease may not be affected by the type of stent. This study assessed and compared 2-year clinical outcomes of 304 ...
Marino Marcello - - 2010
Postoperative ischemia may complicate cardiac surgery, despite myocardial protection and recent technical developments. Its medical management in the intensive cardiac care unit is usually efficient, although sometimes it requires the revision of the surgical site. In other cases, urgent coronary angiography and subsequent coronary stenting may resolve the situation. Ostial ...
1 2 3 4 5 6 7 8 9 10 >